Safety Pharmacology in the Era of Precision Medicine. In: Hock, F.J., Pugsley, M.K. (eds) Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays. Springer, Cham, 2024 By: Al-Mahayri, Z.N., Nagy, M.
Utilizing Pharmacogenomic Data for a Safer Use of Statins for the Emirati Population, Current Vascular Pharmacology, 2024
By: Al-qasrawi M, Al-Mahayri Z, Alblooshi H, Alsafar H, Ali Bassam R
Antihypertensives Associated Adverse Events: A Review of Mechanisms and Pharmacogenomic Evidence,
Frontiers in Pharmacology, 14 (2023)
By: Altoum S, Al-Mahayri Z, Ali B
The Utility of CYP2D6 and CYP2C19 Variants to Guide Pharmacological Treatment in Complex Unipolar Major Depression: A Pilot Longitudinal Study, Psychiatric Quarterly, July 2023
By: Reshma Ramaraj · Zeina N. Al-Mahayri · Reema Saleous · Karim Abdel Aziz Fadwa Al-Mugaddam · Mouza Al-Sabousi· Aysha Alhassani· Noura Ali Al Ahbabi Emmanuel Stip · George P. Patrinos · Bassam R. Ali · Danilo Arnone
Opinion: Pharmacogenomics at the Post-Pandemic: If not now, then when?, Frontiers in Pharmacology, 2022 Sep 26
By Zeina N. Al-Mahayri
Pharmacogenomics Implementation in Cardiovascular Disease in a Highly Diverse Population: Initial Findings and Lessons Learned from a Pilot Study in United Arab Emirates. Human Genomics, 2022 Sep 25;16(1):42
Al-Mahayri Z, Khasawneh L, Alqasrawi M, Sahar Altoum, Gohar Jamil, Sally Badawi, Dana Hamza, Lizy George, Anwar AlZaabi, Husam Ouda, Fatima Al-Maskari, Juma AlKaabi, George P. Patrinos, Bassam R. Ali
Mendelian Randomization in Pharmacogenomics: The Unforeseen Potentials, Biomedicine and Pharmacotherapy, 2022 Jun;150:112952.
By: Khasawneh L, Al-Mahayri Z N, Ali B R.
Long-term Effects of Pediatric Acute Lymphoblastic Leukemia Chemotherapy: Can Recent Findings Inform Old Strategies?, Frontiers in Oncology, 2021 By: Al-Mahayri Z, AlAhmad M. & Ali B
Clinical implementation of drug-metabolizing gene-based therapeutic interventions worldwide, Human Genetics, 2021
By: Tsermpini E, Al-Mahayri Z, Ali B, Patrinos G
Current opinion on the pharmacogenomics of paclitaxel-induced toxicity. Expert Opin Drug Metab Toxicol, 2021
By: Al-Mahayri Z, AlAhmad M. & Ali B.
Pharmacogenetic variants of 100 genes among Southeast Asian populations under the collaboration of SEAPharm network. Human Genome Variation, 2021.
By: Runcharoen C, Fukunaga K, Sensorn I, Iemwimangsa N, Klumsathian S, Tong H, Sy Vo N, Le L, Hlaing T M, Thant M, Zain S M, Mohamed Z, Capule F, Nevado Jr. J, Silao C L, Al-Mahayri Z, Ali B R, et al.
Variation in 100 Very Important Pharmacogenes Among Emiratis: Insights from Understudied Populations. Scientific Reports, 2020.
By: Al-Mahayri Z., Patrinos G, Wattanapokayakit S, Iemwimangsa N, Fukunaga K, Mushiroda T, Chantratita W & Ali B
Association of variants in PTPN22, CTLA-4, IL2-RA and INS genes with Type 1 diabetes in Emiratis, Annals of Human Genetics, 2020.
By: Sharma C, Ali B A, Osman W, Afandi B, Aburawi E, Beshyah S, Al-Mahayri Z, Al-Rifai R, Al Yafei Z, ElGhazali G, Alkaabi J.
Toxicity and Pharmacogenomic Biomarkers in Breast Cancer Chemotherapy”. Frontiers in Pharmacology. 2020, 11: 445.
By: Al-Mahayri Z, Patrinos G, & Ali B.
VKORC1 Variants as Significant Predictors of Warfarin Dose in Emiratis. Pharmacogenomics and Personalized Medicine, 2019, 12: 47-57
By: Al-Mahayri Z*, Al-Jaibeji H, Saab* Y, Souliman K, Al-Gazali L, Patrinos G, Ali B.
Pharmacogenomics in Pediatric Acute Lymphoblastic Leukemia: Promises and Limitations. Pharmacogenomics, 18(7): 2017-0005 (2017)
By: Al-Mahayri Z, Patrinos G, & Ali B.
Genotype-phenotype spectrum of PYCR1-related autosomal recessive cutis laxa. Molecular Genetics and Metabolism. November 2013
By: Dimpopoulou A, Fischer B, Gardeitchik T, Schröter P, Kayserili H, Schlack C, Li Y, Brum J, Barisic I, Castori M, Spaich C, Fletcher E, Mahayri Z, et al.
High prevalence of genetic abnormalities in Middle Eastern patients with idiopathic non-obstructive azoospermia. Journal of Assisted Reproduction and Genetics. 2013, 30(6)799
By: Halabi M., Kenj M., Monem F., Mahayri Z., Abou AlChamat G. & Madania A.
Study of GJB2 Gene Mutations in Syrians with Hearing Loss: High frequency of consanguinity and limited concern of genetic tests. SCLA, 2013, 6(8) [Arabic]
By: Mahayri Z. & Monem F.
Screening GJB2 Gene Mutations in Syrians with Sensorineural Hearing Loss, Middle East Journal of Human Genetics. July 2012 – 1 (2): 80–84
By: Mahayri Z. & Monem F.
A Review of 1125 cases referred for cytogenetic analysis in Syria. Middle East Journal of Human Genetics. January 2012, 1 (1):35-43 https://oce.ovid.com/article/01607934-201201000-00006/HTML
By: Mahayri Z. & Monem F.
contact@zeinaalmahayri.com